Literature DB >> 23523621

Association of methylenetetrahydrofolate reductase A1298C polymorphism but not of C677T with multiple sclerosis in Tunisian patients.

Najiba Fekih Mrissa1, Meriem Mrad, Sarra Klai, Jamel Zaouali, Aycha Sayeh, Chakib Mazigh, Brahim Nsiri, Salem Machgoul, Nasreddine Gritli, Ridha Mrissa.   

Abstract

BACKGROUND AND
OBJECTIVE: Multiple sclerosis (MS) is a chronic neurological disease characterized by central nervous system (CNS) inflammation and demyelination of nerve axons. The aim of this study was to investigate a possible association between the methylenetetrahydrofolate reductase (MTHFR) gene and multiple sclerosis in Tunisian patients. PATIENTS AND METHODS: The genotyping of two missense variants of the methylenetetrahydrofolate reductase (MTHFR) gene, C677T and A1298C was performed in 80 multiple sclerosis patients and 200 healthy controls.
RESULTS: No significant differences were found in the frequency of the MTHFR C677T polymorphism between MS patients and healthy controls. However, the genotype prevalence of the missense variant MTHFR A1298C was significantly different between patients and controls (A/C: 55% versus 7%, p<10(-3); C/C: 13.75% versus 0%, p<10(-3), respectively).
CONCLUSION: Although our preliminary findings suggest no association between the MTHFR C677T variants and MS, there is evidence to suggest a significant association between the MTHFR A1298C polymorphisms and MS.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Methylenetetrahydrofolate reductase polymorphism; Multiple sclerosis

Mesh:

Substances:

Year:  2013        PMID: 23523621     DOI: 10.1016/j.clineuro.2013.02.025

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  8 in total

1.  Meta-analysis of associations between MTHFR and GST polymorphisms and susceptibility to multiple sclerosis.

Authors:  Young Ho Lee; Young Ho Seo; Jae-Hoon Kim; Sung Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Neurol Sci       Date:  2015-07-07       Impact factor: 3.307

Review 2.  Emerging Role for Methylation in Multiple Sclerosis: Beyond DNA.

Authors:  Lindsay M Webb; Mireia Guerau-de-Arellano
Journal:  Trends Mol Med       Date:  2017-05-04       Impact factor: 11.951

Review 3.  Genetic and Molecular Biology of Multiple Sclerosis Among Iranian Patients: An Overview.

Authors:  Meysam Moghbeli
Journal:  Cell Mol Neurobiol       Date:  2019-09-03       Impact factor: 5.046

4.  MTHFR gene C677T and A1298C variants are associated with FMF risk in a Turkish cohort.

Authors:  Ayse Feyda Nursal; Süheyla Kaya; Ozlem Sezer; Nevin Karakus; Serbulent Yigit
Journal:  J Clin Lab Anal       Date:  2017-05-22       Impact factor: 2.352

5.  Association between Genetic Polymorphisms in Methylenetetrahydrofolate Reductase and Risk of Autoimmune Diseases: A Systematic Review and Meta-Analysis.

Authors:  Mao Lu; Ke Peng; Li Song; Li Luo; Peng Liang; Yundan Liang
Journal:  Dis Markers       Date:  2022-05-31       Impact factor: 3.464

6.  The fat mass and obesity-associated FTO rs9939609 polymorphism is associated with elevated homocysteine levels in patients with multiple sclerosis screened for vascular risk factors.

Authors:  Wiliam Davis; Susan J van Rensburg; Frans J Cronje; Lindiwe Whati; Leslie R Fisher; Lize van der Merwe; Dieter Geiger; M Shafick Hassan; Tandi Matsha; Rajiv T Erasmus; Maritha J Kotze
Journal:  Metab Brain Dis       Date:  2014-02-18       Impact factor: 3.584

Review 7.  Neurogenomics in Africa: Perspectives, progress, possibilities and priorities.

Authors:  Rufus O Akinyemi; Mayowa O Owolabi; Tolulope Oyeniyi; Bruce Ovbiagele; Donna K Arnett; Hemant K Tiwari; Richard Walker; Adesola Ogunniyi; Raj N Kalaria
Journal:  J Neurol Sci       Date:  2016-05-06       Impact factor: 3.181

8.  Association Between MTHFR Genetic Variants and Multiple Sclerosis in a Southern Iranian Population.

Authors:  Fakhraddin Naghibalhossaini; Hesam Ehyakonandeh; Alireza Nikseresht; Eskandar Kamali
Journal:  Int J Mol Cell Med       Date:  2015
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.